|
⚲
|
| Keyboard |
| Finnegan Frederick
✚
|
|
|---|---|
| CIK # | 0001291694 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001291694] | |
| 4 | [0001291694] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| SAB Biotherapeutics Inc | |
| Finnegan Frederick |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
SAB Biotherapeutics Inc SABS
Employee Stock Option (right to buy) · derivative
|
2022-03-16 | Grant | 23,453 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Common Stock
|
2021-10-22 | Grant | 38,596 | ||
|
SAB Biotherapeutics Inc SABS
Earnout Rights (Common Stock) · derivative
|
2021-10-22 | Grant | 15,593 | ||
|
SAB Biotherapeutics Inc SABS
Employee Stock Option (right to buy) · derivative
|
2021-10-22 | Grant | 23,264 | ||
|
SAB Biotherapeutics Inc SABS
Earnout Rights (Restricted Stock Units) · derivative
|
2021-10-22 | Grant | 60,152 | ||
|
SAB Biotherapeutics Inc SABS
Employee Stock Option (right to buy) · derivative
|
2021-10-22 | Grant | 125,627 |